Answers are grounded in this paper and cite their sources.
Observational analysis demonstrates HIV-1 protease mutation L23I reduces nelfinavir susceptibility in patients, indicating a pathway to multidrug resistance.
We observed a previously uncharacterized mutation in the protease substrate cleft, L23I, in 31 of 4,303 persons undergoing human immunodeficiency virus type 1 genotypic resistance testing. In combination with V82I, L23I was associated with a sevenfold reduction in nelfinavir susceptibility and a decrease in replication capacity. In combination with other drug resistance mutations, L23I was associated with multidrug resistance and a compensatory increase in replication capacity.
No takes yet. Share an insight, caveat, or question.
Johnston et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: